InvestWiser

ContextVision AB

CONTXOslo BørsHealthcareMarket value 293 m NOK
4.00NOK −6.1%
last day · Price as of 18 November 2026

The answer first

Does ContextVision beat the market?

No, ContextVision has not beaten the market over the last year.

ContextVision+15.3%Oslo Børs (OSEBX)+29.5%
  • The ranking · Quality, value and trend combined

    Better than 91% of Nordic stocks

    • Quality89
    • Value41
    • Trend89

    No. 10 of 195 in healthcare

  • Expectations in the price

    Low expectations

    For the share to return about 9% a year from today's price, it is enough that the cash ContextVision keeps stays flat for 10 years.

Max for seven days

Follow ContextVision with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on ContextVision

From today, at a price of 4.00 NOK. Write why you follow ContextVision, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about ContextVision

Your first answer is free, no account needed.

Do you own ContextVision, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with ContextVision and a few more. Free, no card.

Past year against the exchange and Super Stock
ContextVision+7.2%Oslo Børs (OSEBX)+29.5%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • ContextVision has risen 15.3% over the past year, including dividends.
  • Overall, ContextVision ranks better than 91% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 79.7%. The price is 85.1% below its peak now.

What do analysts think of ContextVision?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

91

Quality, value and trend together. Better than 91% of Nordic stocks.

No. 10 of 195 in healthcare

Quality89
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 37 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.19
  • Asset turnoverSales divided by everything the company owns0.94
  • Return on equityProfit divided by equity+17.5%
  • Cash conversionOperating cash flow divided by profit1.42

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value41
The price · Valuation: the multiples

Medium Fair price: about the same as a typical Nordic stock.

No. 59 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity3.0
  • P/SPrice divided by sales2.5
  • P/EPrice divided by earnings17.3
  • P/CFPrice divided by operating cash flow12.2

The ranking is built on P/E, P/B and P/S.

Trend89
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 25 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+12.7%
  • 6 months+19.4%
  • 9 months+21.2%
  • 12 months+15.3%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−12.1%
3 years, per year
−16.6%
5 years, per year
−29.7%
10 years, per year
−1.3%
Largest fall, 3 years
−79.7%
From a peak to the bottom
From the peak now
−85.1%
How far the price is from the peak
Volatility, 1 year
59.1%
How much the price swings over a year
Beta, 1 year
0.05
How much the price moves when the market moves

Return with dividends reinvested.

About ContextVision

ContextVision AB is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 42 employees.

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women's health, veterinary medicine, and point of-care applications.

See the full analysis of ContextVision.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Oslo Børs

Explore the stock market